News Releases

News and information from The Leukemia & Lymphoma Society

New Therapies for Blood Cancers Emerging at Stunning Pace

White Plains, NY – December 15, 2015 – For the more than one million Americans living with or in remission from a blood cancer, there is more hope than ever for new treatments and even cures, not someday, but today. Clinical findings presented at the 57th American Society of Hematology (ASH) Annual Meeting, in Orlando, December 5-8, made it increasingly clear that new discoveries in precision medicine and immu...

LLS Continues to Lead the Way to Cures and Access for Blood Cancer Patients

White Plains, NY – December 3, 2015 – The Leukemia & Lymphoma Society (LLS) further solidifies its leadership role in finding cures and ensuring access to treatments for patients with blood cancers, with the announcement of significant research advances and patient support programs: More than 100 LLS-funded researchers will share their findings at the 57th American Society of Hematology (ASH) Annual Mee...

Two Myeloma Drugs Win Approval Building Hope for Blood Cancer Patients

White Plains, NY – November 23, 2015 – The Leukemia & Lymphoma Society (LLS) applauds the FDA’s recent approval of two new drugs -- daratumumab and ixazomib -- to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S.  Advances in treatments for many different types of blood cancers a...

Unitio and LLS Partner to Create Online Patient-Caregiver Community

November 2, 2015 – Unitio, Inc., a Boston-based nonprofit organization, and The Leukemia & Lymphoma Society (LLS) today announced a partnership to develop an online patient community that will bring together those affected by blood cancers to share real world experiences and contribute to vital research. This partnership marks the first endeavor in cancer for Unitio, a-first-of-its-kind nonprofit designed to un...

LLS Commits $28.6 Million to New Cancer Research Funding

View full multi-media release with videos and photos here. White Plains, N.Y. (September 30, 2015) – The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderso...

Sarah Cannon Blood Cancer Network Lights The Night To Advance Blood Cancer Care

Contact: Kristin Hoose
(914) 821-8973
kristin.hoose@lls.org -Sarah Cannon and The Leukemia & Lymphoma Society Join Forces
to Redefine Cancer Treatment Landscape- White Plains, NY and Nashville, TN (September 22, 2015) – The Sarah Cannon Blood Cancer Network, one of the largest providers of care for blood cancer patients, has expanded its partnership with The Leukemia &a...

Burlington Stores & LLS Partner to Raise Funds to Fight Cancer

Campaign Launch Set for September, Blood Cancer Awareness Month
  White Plains, NY (September 9, 2015) – Today, Burlington Stores and The Leukemia & Lymphoma Society (LLS) are excited to announce the launch of their 2015 Light the Night Walk fundraising campaign, helping to fund lifesaving blood cancer research to advance new  treatments and cures. For the first time, the campaign’s launch...

LLS Names Grant in Honor of Late Physician/Scientist Robert Arceci

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (September 2, 2015) – The Leukemia & Lymphoma Society (LLS) is proud to honor the memory of the late renowned hematologic oncologist Robert Arceci, M.D., Ph.D., by presenting a grant in his name to a young emerging scientist. Dr. Arceci, a physician/scientist who served as a clinical advisor for LLS and researche...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: